The Science Advisory Board

Cell culture Cell-based analysis Virology Bacteriology Microbiome

FDA researchers describe lessons learned from COVID-19 immunology
Key immunological factors underlying the clinical stages of COVID-19 that could be targeted by therapeutic drugs is outlined in a review by U.S. Food and Drug Administration (FDA) researchers and published in Frontiers in Immunology on May 29. Discuss

New repository may speed COVID-19 drugs to market
As researchers race to find vaccines and treatments for COVID-19, drug repurposing has emerged as potentially the fastest route to get drugs to market. A new research effort aims to speed up the process by creating a repository for data on drugs that have already been used off-label to treat COVID-19. Discuss

Italian study links social isolation to elderly COVID-19 cases
A new study of COVID-19 infections in Italy suggests that factors associated with social isolation help explain why Italy's large senior population has been disproportionately affected by the COVID-19 pandemic. The findings were published May 21 in the journal PLOS One. Discuss

Need for efficiency, COVID-19 vaccine spurs biomanufacturing in 2020
With the urgent need for COVID-19 therapies and vaccines, funding agencies have prioritized biomanufacturing; companies in turn are preparing to ramp up a variety of biologics. The strong demand for bioprocessed medicines in 2020 will continue to drive growth of the industry. Discuss

Will SARS-CoV-2 become an endemic seasonal coronavirus?
U.K. virologists have reviewed over 40 studies on SARS-CoV-2 immunity and discussed how this current knowledge about immune responses can inform virus control strategies. They shared their analysis in an article published in the Journal of General Virology on May 20. Discuss

New platform includes biological similarities to accelerate drug discovery
A new open-access tool provides information on the effects of nearly 1 million compounds in a wide range of biological settings. The new tool, published in Nature Biotechnology on May 18, may change the drug discovery process by moving beyond reliance on chemical information alone. Discuss

Academic lab quickly converts to perform SARS-CoV-2 testing
Academic labs could be converted to perform clinical work and process SARS-CoV-2 diagnostic assays with rapid turnaround times to meet increased demand for testing during the COVID-19 pandemic. Investigators from Boston University and Boston Medical Center provided an outline of how they adapted a lab in an article published online May 10 in Med. Discuss

Human enzymes are implicated in SARS-CoV-2 evolution and spread
Two human deaminase enzymes that edit viral RNA inside cells could have implications for the evolution of SARS-CoV-2 and the spread of the infection, according to a study published in Science Advances on May 18. Discuss

SARS-CoV mAb shown to block SARS-CoV-2
Antibodies from recovered SARS-CoV patients appear to block SARS-CoV-2 infectivity and could help in the development of antiviral treatments or vaccines, according to a new study. The findings were published in Nature on May 18. Discuss

Are interferons a viable therapeutic intervention for COVID-19?
Significantly improved viral clearance and reductions in inflammatory cytokines are observed in COVID-19 patients treated with interferons, according to an exploratory study published in Frontiers in Immunology on May 15. Discuss

1 2 3…17 next »

Conferences

BioProcess International Spring Digital Week
June 15-24

AACR Virtual Annual Meeting 2020 II
June 22-24

2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States

BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands

Bioprocess International West
August 10-13
Santa Clara, California United States

More Conferences »»

Topic	Replies / Views	Last Update
General Discussion

https://academic.oup.com/ve/pages/coronavirus-evolution by Michael	0 / 29	More than 3 days ago by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019 by Mahesh Gupta	0 / 11	More than 3 days ago by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey by Mahesh Gupta	0 / 12	More than 3 days ago by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro by Mahesh Gupta	0 / 15	More than 3 days ago by Mahesh Gupta
Super-precise new CRISPR tool could tackle a plethora of genetic diseases by Mahesh Gupta	0 / 14	More than 3 days ago by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page. Go To Our Community's Forum